Related:Curing HIVVaccines in DevelopmentHIV and AIDS BasicsWhat Is an HIV Elite Controller? Medically Reviewed: Vincent A. Covelli, D.O.Here’s what we know about this very rare group of people living with HIV whose immune systems control the virus on their own. Drugs in DevelopmentIslatravir: What You Need to KnowIslatravir is an experimental drug that is being studied for HIV treatment in combination with other drugs. It has also been studied as an HIV prevention drug. HIV Health IssuesWhat Is the Viral Reservoir, and Why Does It Matter?It’s where HIV hides in the body, ready to spring to life once we stop our medications. But new research suggests there might be ways to kill it—and pave a path toward eliminating HIV from the body completely. HIV Health IssuesWhat Is the Viral Reservoir, and Why Does It Matter?It’s where HIV hides in the body, ready to spring to life once we stop our medications. But new research suggests there might be ways to kill it—and pave a path toward eliminating HIV from the body completely. Curing HIVWhat Is HIV Remission?Medically Reviewed: Evan Wittke, M.D., AAHIVS“HIV remission” is the term experts use when a person’s viral load remains undetectable long after they've stopped taking HIV treatment. Curing HIVWhat Is HIV Remission?Medically Reviewed: Evan Wittke, M.D., AAHIVS“HIV remission” is the term experts use when a person’s viral load remains undetectable long after they've stopped taking HIV treatment. Curing HIVWhat Is “Post-Treatment Control,” and Why Are So Many HIV Researchers Talking About It?The term refers to people with HIV who stay “naturally” undetectable—or nearly so—after going off treatment. There are questions about whether studying this phenomenon could help others get to this point. Curing HIVWhat Is “Post-Treatment Control,” and Why Are So Many HIV Researchers Talking About It?The term refers to people with HIV who stay “naturally” undetectable—or nearly so—after going off treatment. There are questions about whether studying this phenomenon could help others get to this point. HIV Treatment StrategiesHow Elite Controllers Are Helping Develop HIV TreatmentsThere’s much to learn from these people whose bodies maintain an undetectable viral load without medication. HIV Treatment StrategiesHow Elite Controllers Are Helping Develop HIV TreatmentsThere’s much to learn from these people whose bodies maintain an undetectable viral load without medication. Curing HIVCould an HIV Cure Be Based on the Same Breakthrough as the New Treatment for Sickle Cell?Medically Reviewed: Vincent A. Covelli, D.O.CRISPR technology literally snips out DNA to create better health outcomes. One company is hoping it can show the approach could knock out HIV for good. Curing HIVCould an HIV Cure Be Based on the Same Breakthrough as the New Treatment for Sickle Cell?Medically Reviewed: Vincent A. Covelli, D.O.CRISPR technology literally snips out DNA to create better health outcomes. One company is hoping it can show the approach could knock out HIV for good. Curing HIVHIV Is Not Over: Interview With Sharon Lewin, M.D., President of the International AIDS SocietySharon Lewin, M.D., explains why a cure for HIV is still important for the world―even with the availability of effective treatment―and why HIV advocacy mustn't grow complacent. Curing HIVHIV Is Not Over: Interview With Sharon Lewin, M.D., President of the International AIDS SocietySharon Lewin, M.D., explains why a cure for HIV is still important for the world―even with the availability of effective treatment―and why HIV advocacy mustn't grow complacent. Drugs in DevelopmentamfAR Head Kevin Frost Talks About Gene-Therapy HIV Cure Research That the Nonprofit Is FundingamfAR is giving a total of $2.4 million to research teams in the U.S. and Europe. Drugs in DevelopmentamfAR Head Kevin Frost Talks About Gene-Therapy HIV Cure Research That the Nonprofit Is FundingamfAR is giving a total of $2.4 million to research teams in the U.S. and Europe. Managing HIV Drug ResistanceSunlenca Looks Great for Highly Drug-Resistant HIV. Will It Serve a Broader Purpose?Medically Reviewed: Vincent A. Covelli, D.O.The new injectable got folks to undetectable status and boosted T cells in the small trial that led to its FDA approval. Now it’s being tested for broader treatment use—as well as for PrEP. Managing HIV Drug ResistanceSunlenca Looks Great for Highly Drug-Resistant HIV. Will It Serve a Broader Purpose?Medically Reviewed: Vincent A. Covelli, D.O.The new injectable got folks to undetectable status and boosted T cells in the small trial that led to its FDA approval. Now it’s being tested for broader treatment use—as well as for PrEP. HIV Treatment StrategiesHIV Remission: What It Is and Isn’tA cure for HIV remains elusive, but one word that is commonly heard is “remission.” Even though it doesn’t mean eradication of the virus, remission is a good thing. But what exactly is remission? Can HIV go into remission? And how does it differ from a cure? HIV Treatment StrategiesHIV Remission: What It Is and Isn’tA cure for HIV remains elusive, but one word that is commonly heard is “remission.” Even though it doesn’t mean eradication of the virus, remission is a good thing. But what exactly is remission? Can HIV go into remission? And how does it differ from a cure? Curing HIVWhy a Massive Blood Transfusion Can’t Cure HIVMedically Reviewed: Vincent A. Covelli, D.O.James Simmons, D.N.P., M.S.N., RN, explains. Curing HIVWhy a Massive Blood Transfusion Can’t Cure HIVMedically Reviewed: Vincent A. Covelli, D.O.James Simmons, D.N.P., M.S.N., RN, explains. Curing HIVWhat Progress Has Been Made Toward an HIV Cure?The short answer is, “It’s complicated.” But there is hope. Curing HIVWhat Progress Has Been Made Toward an HIV Cure?The short answer is, “It’s complicated.” But there is hope. Personal Stories from the HIV Community‘Elite Controller’ Sandra Harrigan-Thompson Loves Being Involved in Cure ResearchSince discovering she’s an outlier whose HIV doesn’t advance, she’s offered her blood to the National Institutes of Health and to Boston’s Ragon Institute. Personal Stories from the HIV Community‘Elite Controller’ Sandra Harrigan-Thompson Loves Being Involved in Cure ResearchSince discovering she’s an outlier whose HIV doesn’t advance, she’s offered her blood to the National Institutes of Health and to Boston’s Ragon Institute. Load More
